Ben Davis

2.3k citations

33 papers · 1.5k indexed · h-index 19

Computational Theory and Mathematics top 2%
- Computational Drug Discovery Methods 7
Molecular Biology top 10%
- Protein Structure and Dynamics 13
- RNA and protein synthesis mechanisms 4
- Biochemical and Molecular Research 3
- Glycosylation and Glycoproteins Research 2
Virology top 10%
Spectroscopy top 10%
- Mass Spectrometry Techniques and Applications 3
Materials Chemistry
- Enzyme Structure and Function 8
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4

Co-authors: Daniel A. Erlanson Alan R. Fersht Roderick E. Hubbard Martin J. Drysdale I‐Jen Chen Wolfgang Jahnke Fareed Aboul‐ela Mikael Oliveberg
Cited by: Computational Theory and Mathematics Molecular Biology Virology
Journals: Journal of Molecular Biology (6 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Biomolecular NMR (2 papers)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Ben Davis

31 papers receiving 1.4k citations

Peers

Countries citing papers authored by Ben Davis

Since Specialization

Citations

This map shows the geographic impact of Ben Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Davis more than expected).

Fields of papers citing papers by Ben Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Davis. The network helps show where Ben Davis may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ben Davis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ben Davis Line = papers co-authored together Ben Davis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting PTPN22 at Nonorthosteric Binding Sites─A Fragment Approach ACS Omega ·Paola Di Lello,A. K�v�r,Ben Davis,Zoe Daniels,Thomas P. Garner,Lewis Gazzard,Richard Harris,Roderick E. Hubbard,W. Nyland,أحمد مصيلحى,Lena Phyllis Walter,Vasudevarao Kothakotla,Heather Simmonite,Nicholas J. Skelton,Mark Ultsch,Robert Givler,Laura Nunes Paixão,Yoana N. Dimitrova,Kim Huard	2026	0
2	Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensors SLAS DISCOVERY ·Edward A. Fitzgerald,나지훈,SakthiPriya Manivannan,Hanna F. Klein,David J. Hamilton,V. Talibov,Ayundha Evanthi,Charlotte Juton,Maria T. Lindgren,Claes Holmgren,Ben Davis,Peter O’Brien,Maikel Wijtmans,Roderick E. Hubbard,Iwan J. P. de Esch,U. Helena Danielson	2023	12
3	The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory— Shigella spp. Applied Biosafety ·Stuart D. Blacksell,Rezeda Khabibrakhmanova,J Escarpenter-Oriol,Dieter Rüth,Ben Davis,Kathrin Summermatter,Joseph O’Keefe,Doohee Lee,Rüstem ATEŞOĞLU,Indrawati Sendow,Christina M. Scheel,Anthony Ahumibe,Bruno Fellipe Tascheck,Allan Bennett,Kazunobu Kojima,David R. Harper,Keith Hamilton	2023	0
4	A covalent strategy to target intrinsically disordered proteins: Discovery of novel tau aggregation inhibitors European Journal of Medicinal Chemistry ·László Petri,Péter Ábrányi‐Balogh,나지훈,Tı́mea Imre,Cora West,István M. Mándity,Anita Rácz,Lúcia Wittner,Kinga Tóth,贺恭,Tünde Juhász,Ben Davis,György M. Keserű	2022	13
5	Two-dimensional NMR lineshape analysis of single, multiple, zero and double quantum correlation experiments Journal of Biomolecular NMR ·Christopher A. Waudby,Lisa Miller,Ben Davis,John Christodoulou	2020	11
6	Fragment-Based Drug Discovery: Advancing Fragments in the Absence of Crystal Structures Cell chemical biology ·Daniel A. Erlanson,Ben Davis,Wolfgang Jahnke	2018	90
7	Dynamic undocking and the quasi-bound state as tools for drug discovery Nature Chemistry ·Sergio Ruiz‐Carmona,Peter Schmidtke,F. Javier Luque,Lisa Baker,Natalia Matassova,Ben Davis,Stephen D. Roughley,James B. Murray,Rod Hubbard,Xavier Barril	2016	70
8	Screening Protein–Small Molecule Interactions by NMR Methods in molecular biology ·Ben Davis	2013	11
9	Discovery of cell-active phenyl-imidazole Pin1 inhibitors by structure-guided fragment evolution Bioorganic & Medicinal Chemistry Letters ·Andrew Potter,Cai Zhen-zhao,Jinya Ma,Christophe Fromont,Stuart Ray,Christopher J. Northfield,Chris Bryant,Simon Scrace,David A. Robinson,Nushin Hosseini-Eckhardt,Lisa Baker,P. Dokurno,A.E. Surgenor,Ben Davis,Christine M. Richardson,James B. Murray,Jonathan D. Moore	2010	69
10	Structure-guided design of α-amino acid-derived Pin1 inhibitors Bioorganic & Medicinal Chemistry Letters ·Andrew Potter,Stuart Ray,Clara Oliveira Almeida,Jinya Ma,Chris Bryant,Simon Scrace,Natalia Matassova,Lisa Baker,P. Dokurno,David A. Robinson,A.E. Surgenor,Ben Davis,James B. Murray,Christine M. Richardson,Jonathan D. Moore	2009	73
11	The SeeDs Approach: Integrating Fragments into Drug Discovery Current Topics in Medicinal Chemistry ·Roderick E. Hubbard,Ben Davis,I‐Jen Chen,Martin J. Drysdale	2007	57
12	Rational Design of Inhibitors of HIV-1 TAR RNA through the Stabilisation of Electrostatic “Hot Spots” Journal of Molecular Biology ·Ben Davis,Mohammad Afshar,Gabriele Varani,Alastair I.H. Murchie,Jonathan Karn,Georg Lentzen,Martin J. Drysdale,Justin Bower,Andrew Potter,Ian D. Starkey,Peter Sugden H,Fareed Aboul‐ela	2004	134
13	A structure-based strategy to identify new molecular scaffolds targeting the bacterial ribosomal A-site Bioorganic & Medicinal Chemistry ·Nicolas Foloppe,I‐Jen Chen,Ben Davis,Yonglong Shi,Xavier Mourer Alviset,Rob Howes	2004	46
14	Structure-based Drug Design Targeting an Inactive RNA Conformation: Exploiting the Flexibility of HIV-1 TAR RNA Journal of Molecular Biology ·Alastair I.H. Murchie,Ben Davis,Catherine Isel,Mohammad Afshar,Martin J. Drysdale,Justin Bower,Andrew Potter,Ian D. Starkey,Peter Sugden H,優伺内山,Catherine D. Prescott,Philippe Vaglio,Fareed Aboul‐ela,Jonathan Karn	2003	127
15	Solution structure and backbone dynamics of the DNA‐binding domain of mouse Sox‐5 Protein Science ·Peter D. Cary,Christopher M. Read,Ben Davis,Paul C. Driscoll,Colyn Crane‐Robinson	2001	16
16	Solution structure of the C-terminal SH2 domain of the p85α regulatory subunit of phosphoinositide 3-kinase 1 1Edited by P. E. Wright Journal of Molecular Biology ·Gregg Siegal,Ben Davis,Søren M. Kristensen,P. PETRIK,Лисовская Анастасия Олеговна,Robert C. Stein,George Panayotou,Michael D. Waterfield,Paul C. Driscoll	1998	48
17	NMR analysis of the N-terminal SRCR domain of human CD5: engineering of a glycoprotein for superior characteristics in NMR experiments Protein Engineering Design and Selection ·M. McAlister,Ben Davis,Mark Pfuhl,Paul C. Driscoll	1998	16
18	Sequence specific 1H, 13C and15 N resonance assignment of rat CD2 domain 1 Journal of Biomolecular NMR ·J-FAST Group,Mark Pfuhl,Ben Davis,Paul C. Driscoll	1998	3
19	Hydrogen exchange in chymotrypsin inhibitor 2 probed by mutagenesis Journal of Molecular Biology ·José L. Neira,Laura S. Itzhaki,Daniel E. Otzen,Ben Davis,Alan R. Fersht	1997	63
20	Towards the complete structural characterization of a protein folding pathway: the structures of the denatured, transition and native states for the association/folding of two complementary fragments of cleaved chymotrypsin inhibitor 2. Direct evidence for a nucleation-condensation mechanism PubMed ·José L. Neira,Ben Davis,Andreas G. Ladurner,Ashley M. Buckle,G. Gay,Alan R. Fersht	1996	37

About Ben Davis

Ben Davis is a scholar working on Computational Theory and Mathematics, Molecular Biology, Spectroscopy, Biotechnology and Materials Chemistry, having authored 33 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protein Structure and Dynamics (13 papers), Enzyme Structure and Function (8 papers), Computational Drug Discovery Methods (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), RNA and protein synthesis mechanisms (4 papers), Biochemical and Molecular Research (3 papers), Mass Spectrometry Techniques and Applications (3 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Computational Theory and Mathematics (349 citations), Molecular Biology (1.2k citations), Virology (75 citations), Spectroscopy (135 citations) and Materials Chemistry (318 citations). Ben Davis has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Daniel A. Erlanson, Alan R. Fersht, Roderick E. Hubbard, Martin J. Drysdale, I‐Jen Chen, Wolfgang Jahnke, Fareed Aboul‐ela, Mikael Oliveberg, Yee‐Joo Tan and Andrew Potter. Their work appears in journals such as Journal of Molecular Biology, Bioorganic & Medicinal Chemistry Letters, Journal of Biomolecular NMR, SLAS DISCOVERY and Current Topics in Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact